BACE1 and Alzheimer disease: Intranasal insulin restores reductions in insulin receptor (IR) expression and its downstream signaling in the hippocampus/cortex of ICV-STZ rats, which is accompanied by reversal of BACE1/Aβ elevations, impaired cognitive performances and other AD-like traits (Rajasekar et al., 2017).